Covid-19: India did not have huge peak at all, says ICMR DG


New Delhi, Sep 15 | Lauding the nation-wide lockdown, ICMR Director General Balram Bhargava on Tuesday said that the country distributed the Covid-19 curve in such a way that it did not have many deaths and did not witness a huge peak.

The comments came against the backdrop of All India Institute of Medical Sciences Director Dr Randeep Guleria’s statement that India is witnessing a second wave of coronavirus in some areas.

“During the peak in Europe and the US, there were huge numbers of mortalities. We took learning from that and were able to distribute the curve in such a way that we did not have those deaths. This was attributed to the lockdown. We were able to distribute the curve and did not have a huge peak at all,” said Bhargava, at a press conference, on being asked about the second wave.

India on Tuesday reported a spike of 83,000 new coronavirus cases in the last 24 hours, taking the country’s total case tally past 49 lakh. The country’s overall Covid tally stands at 49,30,237 and 9,90,061 of them are active cases.

As far as the vaccine is concerned, indigenous vaccines — Cadila and Bharat Biotech have completed Phase-1 and Serum Institute of India’s “wants to start the Phase-3 trial, which will commence after the clearance is given by the DCGI,” the ICMR chief said.

Union Health Ministry Secretary Rajesh Bhushan, who was also at the press conference, said no one has presently applied for the emergency authorisation of the vaccine.

Emergency authorisation is not only for vaccines but for drugs, with an existing provision in the Drugs and Cosmetic Act for this. It is an accelerated process which permits the regulator to grant permission which is distinct from regular marketing authorisation.

One example is the US FDA giving emergency authorisation to Remdesivir. Similarly, emergency authorisation to Remdesivir was given by the India regulator too.

About the Sputnik vaccine, Bhushan said: “Russia has a good history of vaccine manufacturing and hence, we assume that this vaccine is also good. There is a dialogue going on between the high-level committee of the governments of India and Russia. We are trying to work out its mechanism.”

Sputnik V, an adenovirus vector-based vaccine, was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund and was registered on August 11.

Earlier, NITI Aayog member, Dr. V.K. Paul had said that the Russian government has sought India’s help in manufacturing the Sputnik V vaccine and also to conduct Phase-3 trials or bridging studies in the country.

Source: IANS

Sponsors Posts

Policybazaar Unveils its new brand campaign "AapKiSideHai"

Policybazaar Unveils its new brand campaign

Akshay Kumar delivers the brand’s promise of always being on the customer’s side

Gurugram, 19th Sept, 2020: (Twitter handle: PolicyBazaar), India’s largest online insurance marketplace with over 10 million customers, showcases its commitment to customers in its new television campaign “AapKiSideHai”. The new ad campaign featuring Policybazaar brand ambassador, Akshay Kumar, highlights the brand’s promise of embracing a holistic customer centric approach while helping to bridge the insurance protection gap in India.

Policybazaar’sAapKiSideHai campaign seeks to reassure its customers on being a dependable Insurance partner for them, every step of the way. The brand has always focused on distributing products like term insurance, health insurance, zero commission ULIP’s and motor insurance that are optimal from a customer perspective. Policybazaar is now extending the brand promise beyond the purchase experience to ensure that consumers get the highest levels of service throughout the policy lifecycle.

The new brand campaign reinforces Policybazaar core value of putting the customer first by delivering on its promise of providing a trusted platform for all types of insurance products. The brand is committed to guiding the customer throughout the insurance journey, starting from recommending the right products at affordable pricing, ensuring thatthe policy issuance process is smooth and fast, and, to providing services and claims assistance when needed.

“While we continue to highlight the importance of Health & Term life Insurance through our marketing campaigns, with the brand promise of Policybazaar AapKiSideHai, we also intend to position Policybazaar as a customer centric brand, that is committed to stand by its customers, both pre and post purchase”, said Samir Sethi, Head of Brand Marketing, The new ad series highlights Policybazaar’s unparalleled support to customers, while providing them with the ease of comparing and buying term and health plans online with guidance at each & every step.

Speaking about the TVC launch, Sharat Dhall, Chief Operating Officer, said, “Our ultimate aim is to provide 360-degree assistance to customers that starts from when the policy is bought, to provide assistance when the claim is paid out, should such a situation arise. Winning and maintaining customer trust is a strong ethos within the company and this campaign reflects that. At a time when the world is grappling with a crisis like no other, the brand intends to instill confidence in the customers’ buying decisions by assuring them protection of their futures with the right insurance products & thorough assistance throughout the journey.”

The new brand campaign in its series displays moments of indecision that people may have while investing in protection products. It addresses these queries &emphasizes the importance of nurturing a bond with the consumers thereby creating customer delight.


Please enter your comment!
Please enter your name here